ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008

CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP.

November 16, 2007

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology

April 28, 1978